Document |
Document Title |
WO/2023/276789A1 |
The present invention provides a compound represented by formula (1), formula (2), or formula (3), a salt thereof, or a solvate of these. (In the formulas, R1, R2, and R3 may be the same or differ, and represent a hydrazine group, an N-h...
|
WO/2023/277307A1 |
The present application relates to a strain for producing highly concentrated L-glutamic acid, and an L-glutamic acid production method using same.
|
WO/2023/276980A1 |
The present disclosure pertains to a method for producing aspartic acid whereby impurities can be reduced or eliminated even when a crude product contaminated with a considerable amount of impurities such as amino acids, organic substanc...
|
WO/2022/270597A1 |
[Problem] To provide: a modified enzyme having an aminotransferase activity; and a method for producing an aliphatic monomer using the modified enzyme. [Solution] Provided is a recombinant polypeptide having the following characteristics...
|
WO/2022/270857A1 |
The present application relates to a recombinant microorganism in which the expression of NADH:quinone oxidoreductase is controlled, and a method for producing O-phosphoserine, cysteine, and a derivative of cysteine by using same.
|
WO/2022/265130A1 |
The present application relates to a novel promoter and a target substance production method using same and, more particularly, to: a novel polynucleotide having a promoter activity; a gene expression cassette and a host cell that compri...
|
WO/2022/263504A1 |
The present invention relates to a recombinant Bacillus host cell comprising a polynucleotide encoding a polypeptide of interest or encoding a polypeptide involved in the production of a compound of interest, wherein the host cell is def...
|
WO/2022/257757A1 |
Disclosed is a mutant of a corynebacterium glutamicum dihydrodipicolinate reductase (dapB) gene promoter. Compared with the promoter of a wild-type dapB gene, the promoter activity of the mutant is significantly improved. Also disclosed ...
|
WO/2022/256882A1 |
The present invention relates to extracted microbial lipids, microbial cells comprising the lipid, and extracts thereof. The present invention also relates to use of these lipids, cells and extracts in foods, feedstuffs and beverages.
|
WO/2022/260215A1 |
The present application relates to a novel MdtH variant and a method for producing O-phosphoserine, cysteine, and a derivative of cysteine using same.
|
WO/2022/253890A1 |
The present invention relates to a process for preparing aniline or an aniline derivative, comprising the steps of (I) providing aminobenzoic acid, (II) decarboxylating the aminobenzoic acid to aniline in the presence of an inorganic het...
|
WO/2022/255839A1 |
The present application relates to a novel YhhS variant and a method for producing O-phosphoserine, cysteine, and a derivative of cysteine using same.
|
WO/2022/255160A1 |
The present disclosure relates to a recombinant microorganism capable of efficiently generating L-leucine and an L-leucine production method using the recombinant microorganism. The production method includes (p) generating L-leucine by ...
|
WO/2022/248739A1 |
The present invention relates in a first aspect to an enzymatic method for the production of an L-glufosinate P-alkyl ester. This method is characterized by a step (c) in which an L-glufosinate P-alkyl ester carbamoylate is reacted to gi...
|
WO/2022/242637A1 |
Provided is a method for inexpensively producing L-isoleucine at a higher yield by means of a fermentation method, comprising: using a genetic engineering method to obtain a genetically engineered strain, the genetically engineered strai...
|
WO/2022/245000A1 |
The present application relates to an amino acid-producing microorganism exhibiting enhanced Agl protein activity, and an amino acid production method using same.
|
WO/2022/244809A1 |
[Problem] To provide: with respect to the production of a diamine, a recombinant microorganism and a method for manufacturing a diamine, that realize a simplified process and/or a reduction in effluent treatment costs; and a halophilic a...
|
WO/2022/244932A1 |
The present application relates to a novel promoter and a target substance production method using same and, more particularly, to: a novel polynucleotide having a promoter activity; a gene expression cassette and a host cell which compr...
|
WO/2022/243116A1 |
The present invention relates to a microorganism transformed to be capable of producing guanidinoacetic acid (GAA) having an inactivated amino acid exporter and to a method for the fermentative production of GAA using such microorganism....
|
WO/2022/240071A1 |
The present invention relates to a recombinant microorganism for producing carnosine, histidine and beta-alanine and a method for producing carnosine, histidine and beta-alanine by using same and, more particularly, to: a recombinant mic...
|
WO/2022/239942A1 |
The present application relates to a novel promoter and a method for production of a target substance using same and, more particularly, to a novel polynucleotide having promoter activity, a vector gene carrying same, and a Corynebacteri...
|
WO/2022/237861A1 |
Provided is a method for preparing solid powder of L-glufosinate ammonium free of crystal water. The method comprises: (1) carrying out solid-liquid separation on an L-glufosinate conversion liquid obtained by carrying out biological cat...
|
WO/2022/239953A1 |
Provided are: a 3-methyl-2-oxobutanoate hydroxymethyltransferase variant; a microorganism having enhanced activity of 3-methyl-2-oxobutanoate hydroxymethyltransferase; a composition containing the microorganism for producing pantothenic ...
|
WO/2022/234794A1 |
The present invention addresses the problem of developing new fermentation technology using fermentation by ascomycetous white wood-rotting fungi having mycorrhizal characteristics. In the present invention, vital active substance-contai...
|
WO/2022/234881A1 |
The present application relates to a novel promoter and a target substance production method using same and, more particularly, to a novel polynucleotide having promoter activity, a gene expression cassette and a host cell which comprise...
|
WO/2022/234880A1 |
The present application relates to a novel promoter and a target substance production method using same and, more particularly, to a novel polynucleotide having promoter activity, a gene expression cassette and a host cell which comprise...
|
WO/2022/234836A1 |
Provided is technology for controlling fermentation. A foam surface during fermentation is detected using a non-contact means such as a laser, the degree of foaming is calculated, and the addition of a defoaming agent is controlled accor...
|
WO/2022/231042A1 |
The present application relates to a novel L-valine-producing Corynebacterium glutamicum strain and a method for producing L-valine using the strain.
|
WO/2022/231057A1 |
The present application relates to a novel isocitrate dehydrogenase kinase/phosphatase variant, an Escherichia coli strain comprising the variant, and a method for producing L-tryptophan using the strain.
|
WO/2022/231058A1 |
The present application relates to a novel water-soluble pyridine nucleotide transhydrogenase variant, an Escherichia coli strain comprising the variant, and a method for producing L-tryptophan using the strain.
|
WO/2022/231342A1 |
This application relates to a mutant SpoT protein and a method for producing L-amino acids using same.
|
WO/2022/231049A1 |
The present invention relates to a Corynebacterium glutamicum variant having an improved ability to produce L-lysine and a method for producing L-lysine by using same. The variant can improve the production yield of L-lysine as compared ...
|
WO/2022/228506A1 |
Disclosed are a Glu/Leu/Phe/Val dehydrogenase mutant and an application thereof in the preparation of L-phosphinothricin. When the Glu/Leu/Phe/Val dehydrogenase mutant is aligned with the amino acid sequence of Glu/Leu/Phe/Val dehydrogen...
|
WO/2022/231055A1 |
The present invention relates to a Corynebacterium glutamicum variant having an improved L-lysine production ability, and a method for producing L-lysine by using same. The variant increases or enhances the expression of a gene encoding ...
|
WO/2022/228505A1 |
Disclosed are a D-amino acid oxidase mutant and an application thereof in preparing L-glufosinate. When the D-amino acid oxidase mutant is compared with the amino acid sequence of a D-amino acid oxidase containing the sequence shown in S...
|
WO/2022/231036A1 |
The present application relates to a novel variant, a Corynebacterium glutamicum strain comprising the variant, and a method for producing L-glutamic acid using the strain.
|
WO/2022/229314A1 |
The present invention relates to A process for enzymatic synthesis of amides of formula (III) from amines of formula (I) and compounds of formula (II), characterized in that the lipase is immobilized on a rotary bed reactor or on a spin-...
|
WO/2022/231368A1 |
The present application relates to a novel glutamate synthase subunit alpha variant, a Corynebacterium glutamicum strain comprising the variant, and an L-glutamic acid production method using the strain.
|
WO/2022/231027A1 |
The present application relates to a novel variant, an Escherichia coli strain comprising the variant, and a method for producing L-tryptophan using the strain.
|
WO/2022/231054A1 |
The present invention relates to a Corynebacterium glutamicum variant having improved L-lysine production ability and a method for producing L-lysine using same, wherein the variant can increase or enhance the expression of a gene encodi...
|
WO/2022/231056A1 |
The present invention relates to a Corynebacterium glutamicum variant with improved L-lysine-producing ability, and a method for producing L-lysine using same. The variant can improve the production yield of L-lysine compared to a parent...
|
WO/2022/225254A1 |
The present application relates to an L-amino-acid-producing Corynebacterium sp. microorganism, and a method for producing L-amino acids by using same.
|
WO/2022/220327A1 |
The present application relates to a cell division membrane protein variant, a corynebacterium glutamicum strain comprising the variant, and a method for producing L-lysine using the strain.
|
WO/2022/220328A1 |
The present application relates to a novel protein variant, a corynebacterium glutamicum strain comprising the variant, and a method for producing L-lysine using the strain.
|
WO/2022/220263A1 |
An ergothioneine production method comprising: (a) a step for culturing an alga belonging to Cyanidiophyceae; (b) a step for collecting the alga belonging to Cyanidiophyceae from the culture liquid after the culture; and (c) a step for e...
|
WO/2022/220329A1 |
The present application relates to a major facilitator superfamily permease variant, a corynebacterium glutamicum strain comprising the variant, and a method for producing L-lysine using the strain.
|
WO/2022/220326A1 |
The present application relates to a sugar phosphate isomerase/epimerase variant, a corynebacterium glutamicum strain comprising the variant, and a method for producing L-lysine using the strain.
|
WO/2022/215799A1 |
The present application relates to a novel 2-isopropylmalate synthase variant, a corynebacterium glutamicum strain comprising the variant, and a method for producing L-valine using the strain.
|
WO/2022/217117A1 |
The present invention relates to methods of producing compounds of interest in a recombinant microorganism. In particular, the present invention relates to using a recombinant microorganism comprising a heterologous nucleic acid encoding...
|
WO/2022/215796A1 |
The present application relates to a novel transcriptional regulator variant, a corynebacterium glutamicum strain comprising the variant, and a method for producing L-valine using the strain.
|